| Literature DB >> 27026330 |
E Cavalier1, P Bergmann2, O Bruyère3, P Delanaye4, A Durnez5, J-P Devogelaer5, S L Ferrari6, E Gielen7, S Goemaere8, J-M Kaufman9,10, A Nzeusseu Toukap5, J-Y Reginster10, A-F Rousseau11, S Rozenberg12, A J Scheen13, J-J Body14.
Abstract
The exact role of biochemical markers of bone turnover in the management of metabolic bone diseases remains a topic of controversy. In this consensus paper, the Belgian Bone Club aimed to provide a state of the art on the use of these biomarkers in different clinical or physiological situations like in postmenopausal women, osteoporosis in men, in elderly patients, in patients suffering from bone metastasis, in patients with chronic renal failure, in pregnant or lactating women, in intensive care patients, and in diabetics. We also gave our considerations on the analytical issues linked to the use of these biomarkers, on potential new emerging biomarkers, and on the use of bone turnover biomarkers in the follow-up of patients treated with new drugs for osteoporosis.Entities:
Keywords: Biomarkers; Bone; Osteoporosis
Mesh：
Substances：
Year: 2016 PMID： 27026330 DOI： 10.1007/s00198-016-3561-3
Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507